Gerd Inga-Lill Forslund Larsson
Chief Executive Officer chez Ellet Assets AB
Profil
Gerd Inga-Lill Forslund Larsson is currently the Chief Executive Officer & Director at Ellet Assets AB.
She also holds positions as Chief Executive Officer & Director at Fastighets AB Olshög, Director at Truly Labs AB, Director at Nöbbe Gård Projekt AB, Director at Lu Bioscience AB, and Head-Urology Global Marketing at Ferring Pharmaceuticals A.
Previously, she served as Chairman at Sista versen.
26366 AB and Scandinavian ChemoTech AB.
She was also a Director at LIDDS AB from 2015 to 2022.
Ms. Forslund Larsson obtained an undergraduate degree from the University of Uppsala.
Postes actifs de Gerd Inga-Lill Forslund Larsson
| Sociétés | Poste | Début |
|---|---|---|
Truly Labs AB
 Truly Labs AB Medical/Nursing ServicesHealth Services Truly Labs AB is a Contract Research Organization that provides customized in vitro and in vivo services to its customers. The Swedish company offers a wide range of in vitro services, including cell-based assays such as mode-of-action and efficacy assays, and biomarker analysis. The private company specializes in inhalation, which is relevant for all therapeutic indications where systemic exposure is desired. The company also has a podcast called "Lung in the Lunch and Learn," where the CEO, Karin von Wachenfeldt, and Lars Asking from MVIC AB discuss inhalation. | Director/Board Member | - |
Ellet Assets AB
 Ellet Assets AB Miscellaneous Commercial ServicesCommercial Services Ellet Assets AB owns and manages real estate properties and securities. The company is headquartered in Lund, Sweden. | Chief Executive Officer | 01/01/2001 |
| Fastighets AB Olshög | Chief Executive Officer | - |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
Nöbbe Gård Projekt AB
 Nöbbe Gård Projekt AB Advertising/Marketing ServicesCommercial Services Nöbbe Gård Projekt AB is a private company based in Malmö, Sweden. The Swedish company operates as a platform for condominium associations and residents in condominiums. | Director/Board Member | - |
| Lu Bioscience AB | Director/Board Member | - |
Anciens postes connus de Gerd Inga-Lill Forslund Larsson
| Sociétés | Poste | Fin |
|---|---|---|
| LIDDS AB | Director/Board Member | 02/05/2022 |
| SCANDINAVIAN CHEMOTECH AB | Chairman | - |
Sista versen 26366 AB
 Sista versen 26366 AB Pharmaceuticals: MajorHealth Technology Sista Versen 26366 AB discovers treatments for inflammatory disorders. Their treatment is based on properties of new classes of endogenous host defense peptides from proteins within the coagulation cascade, which display potent immune-modulating properties. The firm develops drugs that prevent sepsis development. The company was founded by Artur Schmidtchen and Nils Martin Malmsten on October 26, 2009 and is headquartered in Lund, Sweden. | Chairman | - |
Formation de Gerd Inga-Lill Forslund Larsson
| University of Uppsala | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LIDDS AB | Health Technology |
| SCANDINAVIAN CHEMOTECH AB | Health Technology |
| Entreprise privées | 7 |
|---|---|
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Health Technology |
Sista versen 26366 AB
Sista versen 26366 AB Pharmaceuticals: MajorHealth Technology Sista Versen 26366 AB discovers treatments for inflammatory disorders. Their treatment is based on properties of new classes of endogenous host defense peptides from proteins within the coagulation cascade, which display potent immune-modulating properties. The firm develops drugs that prevent sepsis development. The company was founded by Artur Schmidtchen and Nils Martin Malmsten on October 26, 2009 and is headquartered in Lund, Sweden. | Health Technology |
Ellet Assets AB
Ellet Assets AB Miscellaneous Commercial ServicesCommercial Services Ellet Assets AB owns and manages real estate properties and securities. The company is headquartered in Lund, Sweden. | Commercial Services |
Truly Labs AB
Truly Labs AB Medical/Nursing ServicesHealth Services Truly Labs AB is a Contract Research Organization that provides customized in vitro and in vivo services to its customers. The Swedish company offers a wide range of in vitro services, including cell-based assays such as mode-of-action and efficacy assays, and biomarker analysis. The private company specializes in inhalation, which is relevant for all therapeutic indications where systemic exposure is desired. The company also has a podcast called "Lung in the Lunch and Learn," where the CEO, Karin von Wachenfeldt, and Lars Asking from MVIC AB discuss inhalation. | Health Services |
Nöbbe Gård Projekt AB
Nöbbe Gård Projekt AB Advertising/Marketing ServicesCommercial Services Nöbbe Gård Projekt AB is a private company based in Malmö, Sweden. The Swedish company operates as a platform for condominium associations and residents in condominiums. | Commercial Services |
| Lu Bioscience AB | |
| Fastighets AB Olshög |
